placebo – A New Vision for Mental Health

Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA

Author: Editorial 20th August 2021 0 Comments

Prof. Peter Gøtzsche has tweeted : “When you stop taking a depression pill and feel bad, psychiatrists tell you that you have relapsed. Not so. By far most, perhaps even all your troubles, are withdrawal symptoms … Never stop abruptly. This…
Read more

collaborative practice

antidepressants, depression, Food & Drug Administration (FDA), Peter Gøtzsche, placebo, prophylactic effects, relapse prevention, Research, Therapeutic Advances in Psychopharmacology, withdrawal confounding

Antidepressants are not antidepressants – an alternative approach to drug action and implications for the use of antidepressants

Author: Editorial 14th February 2019 1 Comment

“Antidepressants are not antidepressants – an alternative approach to drug action and implications for the use of antidepressants” is an article written by Dr. Joanna Moncrieff (psychiatrist) and published in the BJPsych Bulletin (Jan. 30th 2018) as part of their “Against…
Read more

collaborative practice

antidepressants, biochemical imbalance, BJPsych Bulletin, Joanna Moncrieff, placebo, psychiatry, Randomised Control Trials (RCTs)

A radical new hypothesis in medicine: give patients drugs they know don’t work

Author: admin 8th June 2017 0 Comments

The placebo effect is weirder and potentially more useful than we imagined. Harvard medicine professor Ted Kaptchuk is at the bleeding edge of a radical new treatment in medicine: giving patients pills that don’t work. “Our patients tell us it’s…
Read more

collaborative practice

New Approaches, open-label placebos, placebo, placebo effect, psychosomatic, Ted Kaptchuk